SLUPP-332
Selective alpha7 nicotinic acetylcholine receptor agonist that enhances cognitive function, working memory, and attention via hippocampal and prefrontal
Buy more, save more
Total Price
$85
For research & laboratory use only. Not for human consumption.
Half-Life
~1-3 hours
Administration Route
Subcutaneous injection
TREK-1 Channel Modulator
Acts on leak K+ channels in neural circuitry
Pain & Mood
TREK-1 modulation linked to pain sensitisation and depression
Novel Mechanism
Research-stage peptide exploring non-conventional CNS targets
Effect Profile
Focus & Memory
Neuroprotection
Mood & Anxiety
Neuroplasticity
Mechanism of Action
Scientific Research
Biochem Pharmacol (2011)
Neuropsychopharmacology (2007)
Product FAQs
Stacks Well With
Semax
ACTH(4-7) analogue with potent nootropic and neuroprotective properties. Upregulates BDNF and NGF, approved in Russia for stroke recovery and cognitive
Selank
Synthetic heptapeptide anxiolytic developed by the Russian Academy of Sciences. Reduces anxiety without sedation, improves memory consolidation, and
NAD+
Nicotinamide adenine dinucleotide coenzyme found in every living cell. Substrate for sirtuins and PARP enzymes; declines with age. Studied for metabolic
Related Products
Semax
ACTH(4-7) analogue with potent nootropic and neuroprotective properties. Upregulates BDNF and NGF, approved in Russia for stroke recovery and cognitive
Selank
Synthetic heptapeptide anxiolytic developed by the Russian Academy of Sciences. Reduces anxiety without sedation, improves memory consolidation, and
NAD+
Nicotinamide adenine dinucleotide coenzyme found in every living cell. Substrate for sirtuins and PARP enzymes; declines with age. Studied for metabolic